NRX Pharmaceuticals annual return on equity
2018
2019
2022
NRX Pharmaceuticals Return on Equity (ROE) Growth & History (NRXP)
NRX Pharmaceuticals's return on equity was −281.79% for fiscal 2022.
View full NRX Pharmaceuticals company overviewNRX Pharmaceuticals annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −281.79% | — |
| 2019 | 2019-12-31 | 520.27% | +518.95 pp |
| 2018 | 2018-12-31 | 1.32% | — |
NRX Pharmaceuticals quarterly return on equity
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2023 | 2023-03-31 | −154.72% | −103.49 pp |
| Q4 2022 | 2022-12-31 | −84.67% | +14.47 pp |
| Q3 2022 | 2022-09-30 | −43.11% | — |
| Q2 2022 | 2022-06-30 | −24.48% | — |
| Q1 2022 | 2022-03-31 | −51.24% | — |
| Q4 2021 | 2021-12-31 | −99.13% | — |
| Q4 2019 | 2019-12-31 | −18.79% | −19.38 pp |
| Q3 2019 | 2019-09-30 | 1.18% | +0.62 pp |
| Q2 2019 | 2019-06-30 | 3.52% | +3.65 pp |
| Q1 2019 | 2019-03-31 | 3.76% | +3.45 pp |
| Q4 2018 | 2018-12-31 | 0.58% | — |
| Q3 2018 | 2018-09-30 | 0.56% | — |
| Q2 2018 | 2018-06-30 | −0.13% | — |
| Q1 2018 | 2018-03-31 | 0.31% | — |
NRX Pharmaceuticals return on equity trends
Between the periods ended 2018-12-31 and 2022-12-31, NRX Pharmaceuticals's return on equity decreased from 1.32% to −281.79%, a change of −283.12 percentage points. The latest reported quarter, Q1 2023, shows −154.72%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NRX Pharmaceuticals source filings ↗